Calliditas is a clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs. Show more

Location: Kungsbron 1, Stockholm, 111 22, Sweden | Website: https://www.calliditas.se/ | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

0.00

52 Wk Range

$N/A - $N/A

Previous Close

$40.00

Open

$40.00

Volume

N/A

Day Range

$40.00 - $40.00

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

3.81%

Institutional Own.

0.32%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Quarterly sales

Approved

Quarterly sales

Setanaxib Details
Primary biliary cholangitis, Liver disease

Phase 2b

Update

Setanaxib Details
Alport Syndrome

Phase 2

Data readout

Setanaxib Details
Idiopathic pulmonary fibrosis

Phase 2

Update

Setanaxib Details
Cancer, Solid tumor/s, Head and neck squamous cell carcinoma

Phase 2

Update